{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:52:04Z","timestamp":1792003924739,"version":"4.4.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T00:00:00Z","timestamp":1701993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T00:00:00Z","timestamp":1701993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Interv and Ther"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s12928-023-00972-5","type":"journal-article","created":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T11:02:45Z","timestamp":1702033365000},"page":"191-199","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Feasibility of contrast-free left atrial appendage closure with WATCHMAN FLX device for patients with chronic kidney disease"],"prefix":"10.1007","volume":"39","author":[{"given":"Azusa","family":"Okada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4794-7843","authenticated-orcid":false,"given":"Shunsuke","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuki","family":"Chatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Mushiake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Nishiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiyo","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Maruo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazushige","family":"Kadota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,8]]},"reference":[{"key":"972_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j5058","volume":"359","author":"JA L\u00f3pez-L\u00f3pez","year":"2017","unstructured":"L\u00f3pez-L\u00f3pez JA, Sterne JAC, Thom HHZ, Higgins JPT, Hingorani AD, Okoli GN, et al. Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis. BMJ. 2017;359: j5058.","journal-title":"BMJ"},{"key":"972_CR2","doi-asserted-by":"publisher","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","volume":"146","author":"RG Hart","year":"2007","unstructured":"Hart RG, Pearce LA, Aguilar MI. Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857\u201367.","journal-title":"Ann Intern Med"},{"key":"972_CR3","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/0003-4975(95)00887-X","volume":"61","author":"JL Blackshear","year":"1996","unstructured":"Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 1996;61:755\u20139.","journal-title":"Ann Thorac Surg"},{"key":"972_CR4","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1001\/jama.2014.15192","volume":"312","author":"VY Reddy","year":"2014","unstructured":"Reddy VY, Sievert H, Halperin J, Doshi SK, Buchbinder M, Neuzil P, et al. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation. A randomized clinical trial. JAMA. 2014;312:1988\u201398.","journal-title":"JAMA"},{"key":"972_CR5","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","volume":"70","author":"VY Reddy","year":"2017","unstructured":"Reddy VY, Doshi SK, Kar S, Gibson DN, Price MJ, Huber K, et al. 5-year Outcomes after Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials. J Am Coll Cardiol. 2017;70:2964\u201375.","journal-title":"J Am Coll Cardiol"},{"key":"972_CR6","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1053\/j.ajkd.2013.02.381","volume":"62","author":"KP Ng","year":"2013","unstructured":"Ng KP, Edwards NC, Lip GY, Townend JN, Ferro CJ. Atrial fibrillation in CKD: Balancing the risks and benefits of anticoagulation. Am J Kidney Dis. 2013;62:615\u201332.","journal-title":"Am J Kidney Dis"},{"key":"972_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1161\/CIRCINTERVENTIONS.112.974493","volume":"6","author":"MT James","year":"2013","unstructured":"James MT, Samuel SM, Manning MA, Tonelli M, Ghali WA, Faris P, et al. Contrast-induced acute kidney injury and risk of adverse clinical outcomes after coronary angiography: A systematic review and meta-analysis. Circ Cardiovasc Interv. 2013;6:37\u201343.","journal-title":"Circ Cardiovasc Interv"},{"key":"972_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s12928-020-00660-8","volume":"35","author":"R Chandiramani","year":"2020","unstructured":"Chandiramani R, Cao D, Nicolas J, Mehran R. Contrast-induced acute kidney injury. Cardiovasc Interv Ther. 2020;35:209\u201317.","journal-title":"Cardiovasc Interv Ther"},{"key":"972_CR9","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1161\/CIRCULATIONAHA.120.050117","volume":"143","author":"S Kar","year":"2021","unstructured":"Kar S, Doshi SK, Sadhu A, Horton R, Osorio J, Ellis C, et al. Primary outcome evaluation of a next-generation left atrial appendage closure device: results from the PINNACLE FLX trial. Circulation. 2021;143:1754\u201362.","journal-title":"Circulation"},{"key":"972_CR10","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.jacep.2022.12.029","volume":"9","author":"T Chakravarty","year":"2023","unstructured":"Chakravarty T, Leong D, Bhardwaj N, Singwine C, Zung L, Friedman J, et al. Zero-contrast Percutaneous left atrial appendage occlusion with WATCHMAN FLX device. JACC Clin Electrophysiol. 2023;9:1004\u20135.","journal-title":"JACC Clin Electrophysiol"},{"key":"972_CR11","first-page":"213","volume":"7","author":"N Messas","year":"2018","unstructured":"Messas N, Ibrahim R. The Amplatzer amulet device: Technical Considerations and Procedural Approach. Interv Cardiol Clin. 2018;7:213\u20138.","journal-title":"Interv Cardiol Clin"},{"key":"972_CR12","doi-asserted-by":"crossref","unstructured":"Lam YY, Yan BP, Doshi SK, Li A, Zhang D, Kaya MG, et,al. Preclinical evaluation of a new left atrial appendage occluder (Lifetech LambreTM Device) in a canine model. Int J Cardiol, 2013;168:3996\u20134001.","DOI":"10.1016\/j.ijcard.2013.06.083"},{"key":"972_CR13","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/j.jcin.2017.06.072","volume":"10","author":"H Huang","year":"2017","unstructured":"Huang H, Liu Y, Xu Y, Wang Z, Li Y, Cao K, et al. Percutaneous left atrial appendage closure with the Lambre device for stroke prevention in atrial fibrillation: a prospective, multicenter clinical study. JACC Cardiovasc Interv. 2017;10:2188\u201394.","journal-title":"JACC Cardiovasc Interv"},{"key":"972_CR14","doi-asserted-by":"publisher","first-page":"1012731","DOI":"10.3389\/fcvm.2022.1012731","volume":"9","author":"Z Jingquan","year":"2022","unstructured":"Jingquan Z, Deyong L, Huimin C, Hua F, Xuebin H, Chenyang J, et al. Intracardiac echocardiography Chinese expert consensus. Front Cardiovasc Med. 2022;9:1012731.","journal-title":"Front Cardiovasc Med"},{"key":"972_CR15","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.jcin.2022.10.024","volume":"16","author":"JE Nielsen-Kudsk","year":"2023","unstructured":"Nielsen-Kudsk JE, Berti S, Caprioglio F, Ronco F, Arzamendi D, Betts T, et al. Intracardiac echocardiography to guide Watchman FLX implantation: The ICE LAA study. JACC Cardiovasc Interv. 2023;16:643\u201351.","journal-title":"JACC Cardiovasc Interv"},{"key":"972_CR16","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1080\/24748706.2019.1686193","volume":"4","author":"RJ Perez","year":"2020","unstructured":"Perez RJ, Amin A, Yakubov SJ, Sanchez CE. First reported 4D volume intracardiac echocardiography guided left atrial appendage closure in the USA. Struct Heart. 2020;4:72\u20134.","journal-title":"Struct Heart"}],"container-title":["Cardiovascular Intervention and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-023-00972-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12928-023-00972-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-023-00972-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T02:06:47Z","timestamp":1710468407000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12928-023-00972-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,8]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["972"],"URL":"https:\/\/doi.org\/10.1007\/s12928-023-00972-5","relation":{},"ISSN":["1868-4300","1868-4297"],"issn-type":[{"value":"1868-4300","type":"print"},{"value":"1868-4297","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,8]]},"assertion":[{"value":"26 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Kubo is a clinical proctor for Boston Scientific.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}